-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IoQ/SCzXag5lDjCSjqEzbwwAM9xdzM97IYxdiybICWo8XOpXeJcpNlwajw4zSo5a q9WAlVZxee+IKKkS4eJcRw== 0001104659-09-046905.txt : 20090804 0001104659-09-046905.hdr.sgml : 20090804 20090804160925 ACCESSION NUMBER: 0001104659-09-046905 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090804 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090804 DATE AS OF CHANGE: 20090804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COHERENT INC CENTRAL INDEX KEY: 0000021510 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941622541 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33962 FILM NUMBER: 09983697 BUSINESS ADDRESS: STREET 1: 5100 PATRICK HENRY DR CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: 4087644000 MAIL ADDRESS: STREET 1: 5100 PATRICK HENRY DRIVE STREET 2: MAIL STOP P38 CITY: SANTA CLARA STATE: CA ZIP: 95054 FORMER COMPANY: FORMER CONFORMED NAME: COHERENT RADIATION DATE OF NAME CHANGE: 19770604 8-K 1 a09-20865_18k.htm 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported):  August 4, 2009

 

COHERENT, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33962

 

94-1622541

(State or other jurisdiction of

incorporation)

 

(Commission File No.)

 

(IRS Employer Identification

Number)

 

5100 Patrick Henry Drive

Santa Clara, CA 95054

(Address of principal executive offices)

 

(408) 764-4000

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 2.02.                                    Results of Operations and Financial Condition

 

On August 4, 2009, Coherent, Inc. (the “registrant” or “Coherent”) issued a press release regarding its financial results for the fiscal quarter ended July 4, 2009. A copy of the press release is furnished as Exhibit 99.1 to this report.

 

NON-GAAP FINANCIAL MEASURES: Coherent utilizes a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall business performance, for making operating decisions and for forecasting and planning future periods. Coherent considers the use of non-GAAP financial measures helpful in assessing its current financial performance, ongoing operations and prospects for the future. Ongoing operations are the ongoing revenue and expenses of the business, excluding certain costs that Coherent does not anticipate to recur on a quarterly basis or which do not reflect ongoing operations. While Coherent uses non-GAAP financial measures as a tool to enhance its understanding of certain aspects of its financial performance, Coherent does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. Consistent with this approach, Coherent believes that disclosing non-GAAP financial measures to the readers of its financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial measures, allows for greater transparency in the review of its financial and operational performance. In assessing the overall health of its business, Coherent excluded items in the following general categories described below:

 

Net income (loss) and net income (loss) per basic or diluted share.  We have excluded certain recurring and non-recurring items  in order to enhance investors’ understanding of our ongoing operations and to compare these results across multiple fiscal periods, particularly where a one-time event may have an impact in one fiscal quarter and not another.

 

Each of the non-GAAP financial measures described above, and used herein, should not be considered in isolation from, or as a substitute for, a measure of financial performance prepared in accordance with GAAP. Further, investors are cautioned that there are inherent limitations associated with the use of each of these non-GAAP financial measures as an analytical tool. In particular, these non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles and many of the adjustments to the GAAP financial measures reflect the exclusion of items that are recurring and will be reflected in Coherent’s financial results for the foreseeable future. In addition, other companies, including other companies in Coherent’s industry, may calculate non-GAAP financial measures differently than Coherent does, limiting their usefulness as a comparative tool.

 

ITEM 9.01.                                    Financial Statements and Exhibits

 

(d)                                 Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated August 4, 2009

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

COHERENT, INC.

Date: August 4, 2009

 

 

By:

/s/ Bret M. DiMarco

 

Bret M. DiMarco

 

Executive Vice President and

 

General Counsel

 

3


EX-99.1 2 a09-20865_1ex99d1.htm EX-99.1

Exhibit 99.1

 

@coherent

PRESS RELEASE

 

 

Editorial Contact:

For Release:

Leen Simonet

IMMEDIATE

(408) 764-4161

August 4, 2009

 

No. 1222

 

Coherent, Inc. Reports Third Fiscal Quarter Results

 

SANTA CLARA, CA, August 4, 2009 — Coherent, Inc. (NASDAQ, COHR) today announced financial results for its third fiscal quarter ended July 4, 2009, posting net sales of $98.5 million and a net loss, on a U.S. generally accepted accounting principles (GAAP) basis, of $7.0 million ($0.29 per share).  These results compare to net sales of $157.0 million and net income of $8.4 million, or $0.35 per diluted share, for the third quarter of fiscal 2008.

 

Non-GAAP net loss for the third quarter of fiscal 2009 was $2.2 million or $0.09 per share after excluding after tax stock-related compensation expense of $1.4 million ($0.06 per share), restructuring expense of $3.4 million, net of tax ($0.14 per share) and an after tax charge of $0.1 million related to litigation resulting from our internal stock option investigation ($0.00 per share). Net income for the third quarter of fiscal 2008 included after tax stock-related compensation expense of $2.0 million ($0.08 per diluted share), restructuring expense of $1.4 million, net of tax ($0.06 per diluted share) and an after tax charge of $0.9 million related to litigation resulting from our internal stock option investigation ($0.04 per diluted share). Excluding these charges, non-GAAP net income for the third quarter of fiscal 2008 was $12.7 million or $0.53 per diluted share.

 

In comparison, net sales for the second quarter of fiscal 2009 were $105.4 million and net loss, on a GAAP basis, was $9.1 million ($0.38 per share). Non-GAAP net income for the second quarter of fiscal 2009 was $0.3 million or $0.01 per diluted share after excluding after tax stock-related compensation expense of $2.0 million ($0.08 per share), restructuring expense of $4.5 million, net of tax ($0.18 per share), an after tax charge of $0.4 million related to litigation resulting from our internal stock option investigation ($0.01 per share) and a non-cash tax expense resulting from a recently enacted change in state tax law of $2.7 million ($0.11 per share).

 

Orders received during the three months ended July 4, 2009 of $88.6 million decreased 40.5% from the same prior year period and decreased by 5.5% compared to orders received in the immediately preceding quarter.  The book-to-bill ratio was 0.90, resulting in backlog of $137.6 million at July 4, 2009 compared to a backlog of $145.9 million at April 4, 2009 and a backlog of $188.6 million at June 28, 2008.

 

As of July 4, 2009, year-to-date sales were $328.3 million and a net loss on a GAAP basis of $30.8 million ($1.27 per share), as compared to the prior year period sales of $457.3 million and a net income of $19.3 million ($0.66 per diluted share).  Orders received for the nine month period ended July 4, 2009 were $285.8 million, compared to $452.5 million in orders received during the same period a year ago.

 

“In what has been a difficult macroeconomic environment, Coherent satisfied several key operational objectives for the third quarter, including quarterly revenues at the high-end of guidance, good cash generation, and the completion of another major component of our footprint consolidation by exiting the Munich facility.  We also executed against our market and product roadmap by introducing a suite of laser solutions targeted at the high-power materials processing market and extensions to our OPS platform for the instrumentation and research markets.  These products will allow us to access new markets and strengthen our position in existing markets,” said John Ambroseo, Coherent’s President and CEO.

 

“We anticipate that total orders will begin their recovery in the current fiscal quarter, led by microelectronics systems and service, and continue through fiscal 2010.  As these orders convert to revenue, we can begin to realize the benefits from our footprint consolidation projects that have thus far been masked by the pullback in revenue,” he concluded.

 



 

Summarized statement of operations information is as follows (unaudited, in thousands except per share data):

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

July 4,

 

April 4,

 

June 28,

 

July 4,

 

June 28,

 

 

 

2009

 

2009

 

2008

 

2009

 

2008

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

98,479

 

$

105,422

 

$

157,024

 

$

328,289

 

$

457,262

 

Cost of sales (A) (B) (E)

 

64,865

 

65,815

 

87,765

 

204,679

 

260,385

 

Gross profit

 

33,614

 

39,607

 

69,259

 

123,610

 

196,877

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research & development (A) (B) (E)

 

15,529

 

15,610

 

19,076

 

45,917

 

56,823

 

Selling, general & administrative (A) (B) (C) (E)

 

29,223

 

27,962

 

39,480

 

80,813

 

115,682

 

Impairment of goodwill(D)

 

 

 

 

19,286

 

 

Intangibles amortization

 

1,907

 

1,894

 

2,165

 

5,744

 

6,600

 

Total operating expenses

 

46,659

 

45,466

 

60,721

 

151,760

 

179,105

 

Income (loss) from operations

 

(13,045

)

(5,859

)

8,538

 

(28,150

)

17,772

 

Other income (expense), net(E)

 

3,329

 

(1,600

)

2,779

 

(2,501

)

12,923

 

Income (loss) before income taxes

 

(9,716

)

(7,459

)

11,317

 

(30,651

)

30,695

 

Provision (benefit) for income taxes(F)

 

(2,701

)

1,671

 

2,915

 

173

 

11,439

 

Net income (loss)

 

$

(7,015

)

$

(9,130

)

8,402

 

$

(30,824

)

$

19,256

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.29

)

$

(0.38

)

$

0.36

 

$

(1.27

)

$

0.67

 

Diluted

 

$

(0.29

)

$

(0.38

)

$

0.35

 

$

(1.27

)

$

0.66

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in computation:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

24,331

 

24,258

 

23,514

 

24,245

 

28,775

 

Diluted

 

24,331

 

24,258

 

24,110

 

24,245

 

29,314

 

 


(A)       Stock-related compensation expense included in operating results is summarized below:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

July 4,

 

April 4,

 

June 28,

 

July 4,

 

June 28,

 

Stock-related compensation expense

 

2009

 

2009

 

2008

 

2009

 

2008

 

Cost of sales

 

$

200

 

$

177

 

$

484

 

$

660

 

$

1,629

 

Research & development

 

249

 

239

 

561

 

683

 

1,688

 

Selling, general & administrative

 

1,039

 

2,009

 

2,275

 

4,260

 

7,657

 

Impact on income (loss) from operations

 

$

1,488

 

$

2,425

 

$

3,320

 

$

5,603

 

$

10,974

 

 

For the quarters ended July 4, 2009, April 4, 2009 and June 28, 2008, the impact on net income (loss), net of tax was  $1,368 ($0.06 per share), $1,972 ($0.08 per share) and $2,031 ($0.08 per diluted share), respectively. For the nine months ended July 4, 2009 and June 28, 2008, the impact on net income (loss), net of tax was $4,493 ($0.19 per share) and  $7,698 ($0.26 per diluted share), respectively.

 



 

(B)       Restructuring costs included in operating results are summarized below:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

July 4,

 

April 4,

 

June 28,

 

July 4,

 

June 28,

 

Restructuring costs

 

2009

 

2009

 

2008

 

2009

 

2008

 

Cost of sales

 

$

2,621

 

$

3,153

 

$

1,328

 

$

8,796

 

$

1,328

 

Research & development

 

799

 

824

 

273

 

2,089

 

273

 

Selling, general & administrative

 

1,469

 

1,023

 

601

 

3,110

 

601

 

Impact on income (loss) from operations

 

$

4,889

 

$

5,000

 

$

2,202

 

$

13,995

 

$

2,202

 

 

For the quarters ended July 4, 2009, April 4, 2009 and June 28, 2008, the impact on net income (loss), net of tax was  $3,354 ($0.14 per share), $4,463 ($0.18 per share) and $1,374 ($0.06 per diluted share), respectively. For the nine months ended July 4, 2009 and June 28, 2008, the impact on net income (loss), net of tax was $10,429 ($0.43 per share) and  $1,374 ($0.05 per diluted share), respectively.

 

(C)       The quarter ended July 4, 2009 includes $108 ($74 net of tax ($0.00 per share)) of costs related to litigation resulting from our internal stock option investigation. The quarter ended April 4, 2009 includes $398 ($356 net of tax ($0.01 per share)) of costs related to litigation resulting from our internal stock option investigation. The quarter ended June 28, 2008 includes $1,533 ($935 net of tax ($0.04 per diluted share)) of costs related to litigation resulting from our internal stock option investigation.  The nine months ended July 4, 2009 includes $948 ($699 net of tax ($0.03 per share)) of costs related to litigation resulting from our internal stock option investigation.  The nine months ended June 28, 2008 includes $8,787 ($5,313 net of tax ($0.18 per diluted share)) of costs related to our restatement of financial statements and litigation resulting from our internal stock option investigation.

 

(D)       The nine months ended July 4, 2009 include a $19,286 ($0.80 per share) non-cash charge for the impairment of all of the goodwill of our Commercial Lasers and Components segment.

 

(E)         Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net.  Deferred compensation expense (benefit) included in operating results is summarized below:

 

 

 

Three Months Ended

 

Nine Months Ended

 

Deferred compensation expense

 

July 4,

 

April 4,

 

June 28,

 

July 4,

 

June 28,

 

(benefit)

 

2009

 

2009

 

2008

 

2009

 

2008

 

Cost of sales

 

$

87

 

$

(54

)

$

35

 

$

(141

)

$

37

 

Research & development

 

309

 

(96

)

161

 

(775

)

130

 

Selling, general & administrative

 

2,431

 

(1,001

)

1,035

 

(4,354

)

392

 

Impact on income (loss) from operations

 

$

2,827

 

$

(1,151

)

$

1,231

 

$

(5,270

)

$

559

 

 

For the quarters ended July 4, 2009, April 4, 2009 and June 28, 2008, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $2,259, expense of $1,222 and income of $773, respectively. For the nine months ended July 4, 2009 and June 28, 2008, the impact on other income (expense) net was expense of $5,761 and income of $596, respectively.

 

(F)         The nine months ended July 4, 2009 and the quarter ended April 4, 2009 include a tax charge of $2,666 ($0.11 per share) resulting from a recently enacted change in state tax law. The nine months ended June 28, 2008 include a tax charge of $1,394 ($0.05 per diluted share) in connection with a dividend from one of our European subsidiaries.

 



 

Summarized balance sheet information is as follows (unaudited, in thousands):

 

 

 

July 4,
2009

 

Sept. 27,
2008

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash, cash equivalents and short-term investments

 

$

221,888

 

$

218,094

 

Restricted cash

 

 

2,645

 

Accounts receivable, net

 

75,120

 

96,611

 

Inventories

 

109,039

 

120,519

 

Prepaid expenses and other assets

 

78,231

 

71,914

 

Total current assets

 

484,278

 

509,783

 

Property and equipment, net

 

99,418

 

100,996

 

Other assets

 

175,451

 

195,604

 

Total assets

 

$

759,147

 

$

806,383

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current portion of long-term obligations

 

$

8

 

$

9

 

Accounts payable

 

18,226

 

26,333

 

Other current liabilities

 

82,244

 

86,985

 

Total current liabilities

 

100,478

 

113,327

 

Other long-term liabilities

 

88,231

 

94,621

 

Total stockholders’ equity

 

570,438

 

598,435

 

Total liabilities and stockholders’ equity

 

$

759,147

 

$

806,383

 

 

Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

July 4,
2009

 

April 4,
2009

 

June 28,
2008

 

July 4,
2009

 

June 28,
2008

 

GAAP net income (loss)

 

$

(7,015

)

$

(9,130

)

$

8,402

 

$

(30,824

)

$

19,256

 

Stock option investigation and related restatement of financial statements, and litigation expenses

 

74

 

356

 

935

 

699

 

5,313

 

Stock-related compensation expense

 

1,368

 

1,972

 

2,031

 

4,493

 

7,698

 

Impairment of goodwill

 

 

 

 

19,286

 

 

Restructuring costs

 

3,354

 

4,463

 

1,374

 

10,429

 

1,374

 

One-time tax expense

 

 

2,666

 

 

2,666

 

1,394

 

Non-GAAP net income (loss)

 

$

(2,219

)

$

327

 

$

12,742

 

$

6,749

 

$

35,035

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share (loss)

 

$

(0.09

)

$

0.01

 

$

0.53

 

$

0.28

 

$

1.20

 

 

The Company’s conference call scheduled for 1:30 p.m. PT today will include discussions relative to the third quarter results and some comments regarding forward looking guidance on future operating performance. Readers are encouraged to refer to the risk disclosures described in the Company’s reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company.

 



 

Forward-Looking Statements

 

This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to whether and the timing of when new products will allow Coherent to access new markets and strengthen its position in existing markets, the timing and impact of a recovery for total orders and the components thereof, including microelectronics systems and service and the timing and impact to Coherent of a realization of benefits from its footprint consolidation projects.  These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement.  Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with quarterly and annual fluctuations in our net sales and operating results, our exposure to risks associated with worldwide economic slowdowns, our ability to increase our sales volumes and decrease our costs, the impact that our operations and potential acquisitions will have on interest, taxes, depreciation and amortization measurements, changes to the Company’s tax rate as a result of government action, customer acceptance and adoption of our new product offerings, and other risks identified in the Company’s SEC filings.  Readers are encouraged to refer to the risk disclosures described in the Company’s reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company.  Actual results, events and performance may differ materially from those presented herein.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company’s Web site at http://www.coherent.com/ for product and financial updates.

 

5100 Patrick Henry Dr. · P. O. Box 54980, Santa Clara, California  95056—0980 · Telephone (408) 764-4000

 


-----END PRIVACY-ENHANCED MESSAGE-----